Evidence map›Paper›PMID 36553074›Full record

ArticleDiagnostics (Basel, Switzerland)2022

Using Recurrent Neural Networks for Predicting Type-2 Diabetes from Genomic and Tabular Data.

Parvathaneni Naga Srinivasu, Jana Shafi, T Balamurali Krishna, Canavoy Narahari Sujatha, S Phani Praveen, Muhammad Fazal Ijaz

Open access · goldAbstract read
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
19.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 74 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Updates of precision medicine in type 2 diabetes.Cambridge prisms. Precision medicine · 2023
    Review
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 3 countries.

Parvathaneni Naga SrinivasuDepartment of Computer Science and Engineering, Prasad V. Potluri Siddhartha Institute of Technology, Vijayawada 520007, Andhra Pradesh, India.ORCID 0000-0001-9247-9132
Jana ShafiDepartment of Computer Science, College of Arts and Science, Prince Sattam bin Abdul Aziz University, Wadi Ad-Dawasir 11991, Saudi Arabia.ORCID 0000-0001-6859-670X
T Balamurali KrishnaDepartment of Computer Science and Engineering, Dhanekula Institute of Engineering and Technology, Vijayawada 521139, Andhra Pradesh, India.
Canavoy Narahari SujathaDepartment of Electronics and Communication Engineering, Sreenidhi Institute of Science and Technology, Hyderabad 501301, Telangana, India.ORCID 0000-0002-3700-0667
S Phani PraveenDepartment of Computer Science and Engineering, Prasad V. Potluri Siddhartha Institute of Technology, Vijayawada 520007, Andhra Pradesh, India.
Muhammad Fazal IjazDepartment of Intelligent Mechatronics Engineering, Sejong University, Seoul 05006, Republic of Korea.ORCID 0000-0001-5206-272X
Siddhartha Medical College · INPrince Sattam Bin Abdulaziz University · SASejong University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The development of genomic technology for smart diagnosis and therapies for various diseases has lately been the most demanding area for computer-aided diagnostic and treatment research. Exponential breakthroughs in artificial intelligence and machine intelligence technologies could pave the way for identifying challenges afflicting the healthcare industry. Genomics is paving the way for predicting future illnesses, including cancer, Alzheimer's disease, and diabetes. Machine learning advancements have expedited the pace of biomedical informatics research and inspired new branches of computational biology. Furthermore, knowing gene relationships has resulted in developing more accurate models that can effectively detect patterns in vast volumes of data, making classification models important in various domains. Recurrent Neural Network models have a memory that allows them to quickly remember knowledge from previous cycles and process genetic data. The present work focuses on type 2 diabetes prediction using gene sequences derived from genomic DNA fragments through automated feature selection and feature extraction procedures for matching gene patterns with training data. The suggested model was tested using tabular data to predict type 2 diabetes based on several parameters. The performance of neural networks incorporating Recurrent Neural Network (RNN) components, Long Short-Term Memory (LSTM), and Gated Recurrent Units (GRU) was tested in this research. The model's efficiency is assessed using the evaluation metrics such as Sensitivity, Specificity, Accuracy, F1-Score, and Mathews Correlation Coefficient (MCC). The suggested technique predicted future illnesses with fair Accuracy. Furthermore, our research showed that the suggested model could be used in real-world scenarios and that input risk variables from an end-user Android application could be kept and evaluated on a secure remote server.

Indexed as

deep learningPIMA datasetRecurrent Neural NetworksType-2 diabetesweight optimization

Identifiers

PMID36553074
PMCPMC9776641
OpenAlexW4311716514

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.